| Revenues | | 8,398.00 | 8,536.00 | 8,317.00 | 8,643.00 |
| Cost Of Revenue | | 6,155.00 | 6,585.00 | 6,188.00 | 6,362.00 |
| Gross Profit | | 2,243.00 | 1,951.00 | 2,129.00 | 2,281.00 |
| | 845.00 | - | - | - |
| Selling, General, and Administrative | | 845.00 | - | - | - |
| Research and Development | | 358.00 | - | - | - |
| Operating Income/Loss | | 949.00 | 813.00 | 852.00 | 1,226.00 |
| Income/Loss From Equity Method Investments | | 148.00 | 116.00 | 104.00 | 118.00 |
| Income/Loss From Continuing Operations Before Tax | | 934.00 | 791.00 | 830.00 | 1,225.00 |
| Income Tax Expense/Benefit | | 254.00 | 171.00 | 271.00 | 297.00 |
| | 680.00 | 620.00 | 559.00 | 928.00 |
| Available To Common Stockholders, Basic | | 654.00 | 593.00 | 536.00 | 890.00 |
| Attributable To Noncontrolling Interest | | 26.00 | 27.00 | 23.00 | 38.00 |
| Basic Average Shares | | 138.30 | 0.10 | 138.00 | 137.80 |
| Diluted Average Shares | | 138.80 | 0.10 | 138.80 | 138.50 |
| Basic Earnings Per Share | | 4.73 | 4.29 | 3.88 | 6.46 |
| Diluted Earnings Per Share | | 4.71 | 4.27 | 3.86 | 6.43 |
| Common Stock Dividends | 2.00 | 2.00 | 2.00 | 2.00 | 1.82 |
CMI
